Savjetovanja o usklađenom razvrstavanju i označivanju
Savjetovanja o usklađenom razvrstavanju i označivanju
Parties concerned are invited to comment on hazard classes open for consultation, which are indicated in the substance table below.
The indicated hazard classes were assessed and concluded by the dossier submitter in their proposal for harmonised classification and labelling (CLH) of the substance.
A hazard class may be open for commenting even if the dossier submitter did not conclude that it warrants a classification. The CLH consultation lasts for 60 days (unless specified otherwise).
Which hazard classes are open for commenting?
Active substance in plant protection products (PPPs)/biocidal products (BPs): All hazard classes for which the dossier submitter has provided an appropriate information basis, assessment and conclusion, including hazard classes for which classification is not proposed.
All other substances: All hazard classes for which the dossier submitter has proposed classification and provided an appropriate information basis, assessment and conclusion. This could include carcinogenicity, mutagenicity, reproductive toxicity, respiratory sensitisation (CMR-RS) hazard classes for which classification is not proposed by the dossier submitter, but which were assessed in the dossier.
- Hazard classes for which an amendment is proposed by the dossier submitter;
- CMR-RS for which classification is not proposed if the dossier submitter has provided an appropriate information basis, assessment and conclusion.
Further information on the dossier submitter’s assessment of hazard classes and evaluation by the Committee for Risk Assessment (RAC) is available in the document 'Dossier submitter’s assessment of hazard classes and evaluation by RAC'.
Comments during consultation
Comments can be submitted on general issues (e.g. substance identification, physicochemical properties and data sources) and may also request clarifications in the text of the CLH report.
The text of the CLH report will not be updated following the consultation, but the comments will be reflected by the dossier submitter in their response to comments.
Comments related to hazard class can only be given on the hazard classes open for commenting during the consultation in question. These comments can be related to the classification itself, the information considered in the proposal, or the justification of the conclusions.
Please note that RAC may conclude that a classification other than that proposed by the dossier submitter is warranted in its opinion. This is limited to those hazard classes open for commenting during the consultation and for which there is information available in the CLH report.
RAC may also agree to propose a specific concentration limit for a hazard class open for commenting, even if this was not proposed by the dossier submitter. For example, during its assessment, RAC might consider that based on the information in the CLH report, a harmonised classification is warranted for a hazard class even if the dossier submitter has proposed that no classification is necessary.
RAC may also conclude that a more severe or less severe classification should apply than what the dossier submitter has proposed. However, RAC may not conclude on the hazard classes not open for comments during the consultation.
In the event that the substance identity proposed to be classified is a group entry or a substance with various forms, if warranted by the data, RAC may also apply a CLH to a subset of the substance identity proposed to be classified in the CLH dossier that was subject to consultation.
Comments supporting the proposed classification are also encouraged. Additional relevant data can also be submitted relating to the hazard classes open for comments.
Any comments arriving after the commenting deadline will not be included in the Response to Comments table, and will not be responded to by the dossier submitter and RAC.
The comments received during the consultation are available on the Registry of CLH intentions until outcome.
- Harmonised Classification and Labelling (explains the various steps of the process)
- Previous consultations
- Registry of CLH intentions until outcome
Consultations close at 23:59 Helsinki time (EET)
| (tert-butoxymethyl)oxirane [1] (isobutoxymethyl)oxirane [2] |
231-640-0 [1] 223-303-1 [2] |
7665-72-7 [1] 3814-55-9 [2] |
Acute toxicity – inhalation Acute toxicity – dermal Acute Toxicity - oral Reproductive toxicity |
20/01/2025 | 21/03/2025 | Details |
| 1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyran; [galaxolide]; [HHCB] | 214-946-9 | 1222-05-5 | Reproductive toxicity | 27/01/2025 | 28/03/2025 | Details |
| 2,3-epoxypropyl neodecanoate | 247-979-2 | 26761-45-5 | Carcinogenicity | 17/02/2025 | 18/04/2025 | Details |
| allyl glycidyl ether; allyl 2,3-epoxypropyl ether; prop-2-en-1-yl 2,3-epoxypropyl ether | 203-442-4 | 106-92-3 |
Acute toxicity – inhalation Acute toxicity – dermal Acute Toxicity - oral Reproductive toxicity |
20/01/2025 | 21/03/2025 | Details |
| Aluminium Phosphide | 244-088-0 | 20859-73-8 |
Acute toxicity – inhalation Acute toxicity - dermal Acute toxicity - oral |
03/03/2025 | 02/05/2025 | Details |
| Bis(pentane-2,4-dionato)calcium | 243-001-3 | 19372-44-2 |
Acute Toxicity - oral Serious eye damage/eye irritation Skin sensitisation |
20/01/2025 | 21/03/2025 | Details |
| butyl glycidyl ether; butyl 2,3-epoxypropyl ether | 219-376-4 | 2426-08-6 |
Acute toxicity – inhalation Acute toxicity – dermal Acute Toxicity - oral Reproductive toxicity |
20/01/2025 | 21/03/2025 | Details |
| N,N-dicyclohexylbenzothiazole-2-sulphenamide | 225-625-8 | 4979-32-2 | PBT/vPvB | 21/02/2025 | 22/04/2025 | Details |
| napropamide (ISO); (2RS)-N,N-diethyl-2-(1-naphthyloxy)propanamide | 239-333-3 | 15299-99-7 |
Physical hazards Carcinogenicity Germ cell mutagenicity Reproductive toxicity Acute toxicity – inhalation Acute toxicity – dermal Acute toxicity – oral Aspiration hazard Specific target organ toxicity – single exposure Specific target organ toxicity – repeated exposure Skin corrosion/irritation Serious eye damage/eye irritation Respiratory sensitisation Skin sensitisation Hazardous to the aquatic environment Hazardous to the ozone layer |
10/02/2025 | 11/04/2025 | Details |
| potassium bromate | 231-829-8 | 7758-01-2 |
Germ cell mutagenicity Acute toxicity - oral Specific target organ toxicity – single exposure |
10/03/2025 | 09/05/2025 | Details |
| reaction products of ammonium bromide and sodium hypochlorite, generated in-situ | - | - |
Explosives Flammable liquids Self-reactive substances and mixtures Pyrophoric liquids Substances or mixtures which in contact with water emit flammable gases Oxidising liquids Corrosive to metals Acute toxicity – inhalation Acute toxicity – dermal Acute Toxicity - oral Skin corrosion/irritation Serious eye damage/eye irritation Skin sensitisation Germ cell mutagenicity Carcinogenicity Reproductive toxicity Specific target organ toxicity — single exposure Specific target organ toxicity — repeated exposure Hazardous to the aquatic environment Hazardous for the ozone layer |
10/03/2025 | 09/05/2025 | Details |
| resorcinol; 1,3-benzenediol | 203-585-2 | 108-46-3 | Endocrine disruptor for human health | 20/01/2025 | 21/03/2025 | Details |
| sodium bromate | 232-160-4 | 7789-38-0 |
Carcinogenicity Germ cell mutagenicity Acute toxicity - oral Specific target organ toxicity – single exposure |
10/03/2025 | 09/05/2025 | Details |
| Sodium chlorite | 231-836-6 | 7758-19-2 |
Physical hazards Acute toxicity via oral route Acute toxicity via dermal route Skin corrosion/irritation Serious eye damage/eye irritation Germ cell mutagenicity Specific target organ toxicity-repeated exposure Hazardous to the aquatic environment |
20/01/2025 | 21/03/2025 | Details |
| trimagnesium diphosphide; magnesium phosphide | 235-023-7 | 12057-74-8 |
Acute toxicity - inhalation Acute toxicity - dermal Acute toxicity - oral |
03/03/2025 | 02/05/2025 | Details |